v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current Assets:    
Cash and Cash Equivalents $ 1,028,324 $ 3,792,322
Short-Term Investments 19,637,812 22,999,760
Prepaid Expenses and Other Current Assets 957,095 2,042,487
Collaboration Receivables 2,418,022 601,197
Tax Receivables 696,002 270,246
Total Current Assets 24,737,255 29,706,012
Non-Current Assets:    
Property and Equipment, Net 106,843 5,232
Restricted Cash 4,461 4,057
Intangible Assets and In-Process R&D, Net 6,687,100 6,687,100
Operating Lease Right-of-Use Assets 349,017 57,170
Other Assets 61,007 24,913
Total Assets 31,945,683 36,484,484
Current Liabilities:    
Accounts Payable 282,537 415,590
Accrued Expenses 2,540,493 4,588,657
Accrued Collaboration Credit 219,625 981,111
Operating Lease Liabilities 143,327 23,355
Total Current Liabilities 3,185,982 6,008,713
Non-Current Liabilities:    
Contingent Consideration 4,604,456 4,191,490
Deferred Tax Liability 490,690 490,690
Deferred Collaboration Revenue 1,250,000 0
Non-Current Operating Lease Liabilities 287,079 33,815
Total Non-Current Liabilities 6,632,225 4,715,995
Total Liabilities 9,818,207 10,724,708
Commitments and Contingencies (Note 8)
Stockholders’ Equity:    
Preferred Stock, $0.01 Par Value: 10,000,000 shares authorized; 3,750 designated Series A, 0 shares issued and outstanding; 10,000 designated Series B, 0 shares issued and outstanding; 10,000 shares designated Series C, 0 shares issued and outstanding; 20,000 shares designated Series D, 7 shares issued and outstanding; 1,280 shares designated Series E, 0 shares issued and outstanding; 3,908 shares designated Series F, 420 issued and outstanding at June 30, 2025 and December 31, 2024, respectively 4 4
Common Stock, $0.01 Par Value: 150,000,000 shares authorized; 3,433,491 and 3,000,788 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively 272,006 267,679
Additional Paid-In Capital 169,828,797 169,156,374
Accumulated Deficit (147,727,561) (143,382,122)
Accumulated Other Comprehensive Loss (245,770) (282,159)
Total Stockholders’ Equity 22,127,476 25,759,776
Total Liabilities and Stockholders’ Equity $ 31,945,683 $ 36,484,484
Common stock, shares, outstanding (in shares) 3,433,491 3,000,788
Common stock, shares, issued (in shares) 3,433,491 3,000,788

Source

10-Q PDF XBRL Zip